Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | CTH | P32929 | 2/20 | 0.42 |
| ▸ | CBS | P35520 | 1/20 | 0.42 |
| ▸ | THPO | P40225 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 3/20 | 0.40 |
| ▸ | BLM | P54132 | 3/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.38 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.36 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.36 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.35 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.35 |
| ▸ | GABRP | O00591 | 1/20 | 0.35 |
| ▸ | GABRD | O14764 | 1/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28386959 | 1.00 | TSHR (0.42) | TSHRCTHCBSTHPOTHRB | |
| SCHEMBL22806980 | 1.00 | TSHR (0.42) | TSHRCTHCBSTHPOTHRB | |
| SCHEMBL1594769 | 1.00 | TSHR (0.42) | TSHRCTHCBSTHPOTHRB | |
| SCHEMBL26111100 | 1.00 | TSHR (0.42) | TSHRCTHCBSTHPOTHRB | |
| SCHEMBL13599228 | 1.00 | TSHR (0.42) | TSHRCTHCBSTHPOTHRB | |
| SCHEMBL1170690 | 1.00 | TSHR (0.42) | TSHRCTHCBSTHPOTHRB | |
| SCHEMBL164253 | 1.00 | TSHR (0.42) | TSHRCTHCBSTHPOTHRB | |
| Hydrochloric Acid SCHEMBL9788713 | 0.98 | THRB (0.44) | TSHRCTHCBSTHPOTHRB | |
| Hydrochloric Acid SCHEMBL17941286 | 0.98 | THRB (0.44) | TSHRCTHCBSTHPOTHRB | |
| SCHEMBL303946 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7935 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746919-A1 | AGENTS AND METHODS FOR TARGETED DELIVERY OF CYTOKINES TO IMMUNE CELLS | BioNTech SE (DE) | 2026-05-27 | — | — | EP | claimed |
| CN-122055385-A | Reagents and methods for targeted delivery of immune effector cells | 百欧恩泰欧洲股份公司 | 2026-05-15 | — | — | CN | claimed |
| WO-2026101534-A1 | MYOSTATIN AND ACTIVIN A IMMUNOGENS AND METHODS OF USE | VAXXINITY, INC. (US) | 2026-05-15 | — | — | WO | claimed |
| US-20260125428-A1 | SYNTHETIC TRIPLEX PEPTIDE NUCLEIC ACID-BASED INHIBITORS FOR CANCER THERAPY | UNIV CONNECTICUT (US) | 2026-05-07 | — | — | US | claimed |
| EP-4736944-A2 | POLYPEPTIDES AND USES THEREOF | MedImmune Limited (GB) | 2026-05-06 | — | — | EP | claimed |
| US-12620459-B2 | High efficacy functional ingredient blends | STOKELY-VAN CAMP, INC. (US) | 2026-05-05 | — | — | US | claimed |
| US-20260116848-A1 | Synthesis of an Intermediate and Its Use for the Preparation of GLP-1R/GIPR Agonists | CARMOT THERAPEUTICS INC. (US) | 2026-04-30 | — | — | US | claimed |
| US-20260116944-A1 | NOVEL TRIPLE GLP-1/GIP/GLUCAGON RECEPTOR AGONIST AND A PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OBESITY COMPRISING THE SAME | HANMI PHARM. CO., LTD. (KR) | 2026-04-30 | — | — | US | claimed |
| US-12612619-B2 | Compositions and methods for improved gene editing | UNIVERSITY OF MASSACHUSETTS (US) | 2026-04-28 | — | — | US | claimed |
| EP-4724471-A1 | GLP-1/GIP DUAL, GLP-1/GCG DUAL AND GLP-1/GIP/GCG TRIPLE RECEPTOR AGONISTS | Sun Pharmaceutical Industries Limited (IN) | 2026-04-15 | — | — | EP | claimed |
| US-20020183249-A1 | Method of identifying inhibitors of CDC25 | TAYLOR NEIL R (AU) | 2002-12-05 | — | — | US | claimed |
| WO-2002095022-A2 | SEQUENCE-SPECIFIC DNA BINDING COMPOUNDS AND THEIR USE IN TARGETING TELOMERES AND OTHER DNA SEQUENCES | UNIVERSITE DE GENEVE (CH) | 2002-11-28 | — | — | WO | claimed |
| US-20020169296-A1 | Linked, sequence-specific DNA-binding molecules | UNIVERSITE DE GENEVE (CH) | 2002-11-14 | — | — | US | claimed |
| WO-2002070680-A1 | METHOD OF IDENTIFYING INHIBITORS OF CDC25 | BASF AKTIENGESELLSCHAFT (DE) | 2002-09-12 | — | — | WO | claimed |
| EP-1226237-A2 | METHOD OF IDENTIFYING INHIBITORS OF CDC25 | BASF AKTIENGESELLSCHAFT (DE) | 2002-07-31 | — | — | EP | claimed |
| EP-0988045-A4 | PEPTIDE NUCLEIC ACID MONOMERS AND OLIGOMERS | NIELSEN PETER EIGIL (DK) | 2002-07-24 | — | — | EP | claimed |
| WO-2001016300-A2 | METHOD OF IDENTIFYING INHIBITORS OF CDC25 | BASF AKTIENGESELLSCHAFT (DE) | 2001-03-08 | — | — | WO | claimed |
| JP-2001500387-A | — | — | 2001-01-16 | — | — | JP | claimed |
| EP-0988045-A1 | PEPTIDE NUCLEIC ACID MONOMERS AND OLIGOMERS | NIELSEN, Peter Eigil (DK) | 2000-03-29 | — | — | EP | claimed |
| WO-1998052595-A1 | PEPTIDE NUCLEIC ACID MONOMERS AND OLIGOMERS | ISIS PHARMACEUTICALS, INC. (US) | 1998-11-26 | — | — | WO | claimed |